3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.95
+3.50 (11.49%)
Mar 24, 2026, 1:58 PM CST
Market Cap2.64B -42.5%
Revenue (ttm)324.87M +489.1%
Net Income133.88M
EPS1.71
Shares Out77.84M
PE Ratio19.88
Forward PEn/a
Dividend0.53 (1.74%)
Ex-Dividend Daten/a
Volume262,970
Average Volume192,640
Open31.00
Previous Close30.45
Day's Range30.45 - 36.30
52-Week Range30.15 - 67.90
Beta0.14
RSI34.96
Earnings DateMar 30, 2026

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

Financial Statements